TrialHub

TrialHub

Clinical trials are experiments that test how well new drugs, treatments or devices work in people. Trials progress through Phases I-IV to test a drug candidate, find the appropriate dosage, and look for side effects. The goal is to determine whether a medicine is both safe and effective.

Each new phase of a clinical trial builds on information from previous stages; each designed to find out specific information. The findings from clinical trials are submitted to the U.S. Federal Drug Administration or it’s counterpart European Medicines Agency to review and determine if a new treatment will be approved to go to market.

Clinical trials listed here below aim to find better ways to diagnose, treat or prevent vitiligo. We provide you with information about a trial's purpose, recruitment status, age restrictions, locations, and contact numbers for more details.

Current Trials

15 Sep `20USA, multiple locations
Study to Evaluate RECELL and MKTP for Repigmentation of Stable Vitiligo Lesions

Official Title: Multi-Arm Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

In Brief: This is a prospective...

20 Nov `19Tunis, TUNISIA
Evaluation of the Efficacy of a Dermocosmetic Product

Official Title: Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo

In Brief: Comparative stud...

18 Nov `19New York, USA
Stress Response Pathways in Vitiligo

Official Title: Stress Response Pathways in Vitiligo: A Prospective, Investigator Initiated, Interventional Study With Two Arms

In brief: Current treatments vary in ef...

01 Nov `19Multicenter, USA
Donate blood for vitiligo research study

Vitiligo Research Foundation has teamed up with Sanguine, a provider of at-home clinical research services, to give you the opportunity to contribute to the development of new Vitiligo treatments from home.

03 Oct `19Multicenter, USA
Incyte: Ruxolitinib cream (TRuE-V2)

Official Title: Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

In Brief: The purpose of this study is to evaluate the efficacy and safety of ruxolit...

25 Sep `19Worcester, USA
Dermavant Sciences: Cerdulatinib Gel

Official Title: A Phase 2a, Randomized, Double-Blind, Vehicle-Controlled Study to Assess the Safety, Tolerability, and Systemic Exposure of Cerdulatinib Gel, 0.37% in Adults With Vitiligo.&nbs...

20 Sep `19Multicenter, USA
Incyte: Ruxolitinib cream (TRuE-V1)

Official Title: Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1): A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed b...

17 Jun `19Nice, FRANCE
Glisodin with UVB

Official Title: Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo. A Randomized Double Blind Placebo Controlled Monocentric Study

30 May `19Chicago, USA
Gut and Skin Microbiome

Official Title: The Gut and Skin Microbiome in Vitiligo Disease Progression

In Brief: Investigators plan to perform a pilot study that aims to characterize the mi...

26 Nov `18USA, CANADA, BELGIUM, GERMANY, JAPAN, KOREA, SPAIN, TAIWAN
Pfizer: PF-06651600 and PF-06700841

Official Title: A Phase 2B randomized, double-blind, placebo-controlled, multicenter, dose-ranging study to evaluate the efficacy and safety profile of PF-06651600 with a partially blinded ext...

01 Nov `18Cairo, EGYPT
Skin Color in Stabilization of Vitiligo by UVB

Official Title: Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVB

In Brief: Vitiligo is a disease in which autoimmunity p...

18 Sep `18Xi'an, CHINA
Gut Microbiome and Metabolic Pathways

Official Title: The Gut Microbiome and Metabolic Activity in Patients With Vitiligo

In Brief: Vitiligo is a chronic depigmenting autoimmune-associated skin diseas...

30 Aug `18Yonsei, REPUBLIC OF KOREA
Investigation on the Expression of HMGB1

Official Title: The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, T...

18 Mar `18USA
Aclaris Therapeutics: ATI-50002

Official Title: A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo

In Brief: The main objective of this study is to assess the safety, tolerabili...

01 Jan `18Xi'an, CHINA
Effects of Camouflage on the Life Quality

Official Title: Development and Psychometric Validation of the Chinese Version of Vitiligo Life Quality Index and Effects of Camouflage on the Life Quality of Patients With Vitiligo: A Randomi...

01 Sep `17Baltimore, USA
Early Molecular Changes After NB-UVB

Official Title: Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy

In Brief: This is an investigator-initiated, single-blinded, ascending do...

04 Apr `17Multicenter, USA
Incyte: A Study of Ruxolitinib 1,5% cream

Official Title: A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

In Brief: The purpose of this study will be to examine the efficacy, safety, and t...

Past Trials

  • 13 Apr `18Porto Alegre, BRAZILSurgical Treatment of Vitiligo
    Official Title: Comparative Study of Surgical Treatment of Vitiligo: Microneedling Versus Microneedling With Suspension of Uncultured Epidermal Cells In Brief: A comparative study for the surgical treatment of vitiligo in which the same patient w...
  • 19 Mar `18multicenter, USAAclaris Therapeutics: Topical Solution
    Official title: An Open-Label Pilot Study of the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily in Adult Subjects With Non-Segmental Facial Vitiligo In brief: This is a multicenter, open-label study desig...
  • 11 Aug `17Bydgoszcz, POLANDSimvastatin And Atorvastatin Effect On Vitiligo
    Official Title: The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo (EVRAAS) In Brief: The aim of this study is to evaluate th...
  • 01 Jul `17Chandigarh, INDIAComparison of Surgical Methods
    Official Title: A Comparative Study Between Autologous Mini Punch Grafting, Suction Blister Grafting and Non-Cutured Epidermal Cell Suspension on Resistant Sites in Stable Vitiligo In Brief: Comparing the Efficacy of Three Different Surgical Meth...
  • 21 Apr `17New York, USACelgene: Apremilast with NB-UVB
    Official title: A Split Body Study of the Effects of Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo. Phase II In brief: Procedure: Each participant will be compared with one side of th...
  • 30 Jan `16Multicenter, USAIncyte: Topical Ruxolitinib for the Treatment of Vitiligo
    Official Title: Topical Ruxolitinib for the Treatment of Vitiligo In Brief: The purpose of this study is to determine if topical ruxolitinib 1.5% will provide repigmentation in vitiligo lesions. Description: The hypothesis is that JAK inhibitors...
  • 21 Jan `16Nice, FRANCEEfficacy of Micro-holes
    Official Title: Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin In Brief: The principal objective is to compare the efficacy of laser-assisted dermabrasion + autologous epidermal cells ...

FAQOther Questions

  • Can Ayurveda help with vitiligo?

    People have used herbs and natural remedies to treat skin conditions for centuries. Vitiligo is an auto-immune condition that causes white patches of skin to develop and expand...

  • Shall I take vitamin D for my vitiligo?

    In Brief Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be id...

  • What are risks of oral and topical corticosteroids?

    Corticosteroid drugs (like hydrocortisone, and others) are often used for treating vitiligo. By mimicing the effects of hormones your body produces naturally in your adrenal gla...